Scholar Rock

Scholar Rock

Clinical-stage biopharmaceutical company focused on the discovery and development of innovative medicines for the treatment of serious diseases in which signaling by protein growth factors plays a fundamental role. Learn more

Launch date
Employees
Market cap
€601m
Enterprise valuation
€490m (Public information from Sep 2024)
Cambridge Massachusetts (HQ)

Financials

Estimates*

Edit
Revenues, earnings & profits over time
USD2020202120222023202420252026
Revenues15.4m18.8m33.2m--21.3m136m
% growth(25 %)22 %76 %---538 %
EBITDA(86.9m)(127m)(134m)(168m)---
% EBITDA margin(564 %)(677 %)(405 %)----
Profit(86.5m)(132m)(135m)(166m)(233m)(223m)(143m)
% profit margin(561 %)(700 %)(405 %)--(1045 %)(105 %)
EV / revenue97.2x37.7x12.5x--17.8x2.8x
EV / EBITDA-17.2x-5.6x-3.1x-7.7x---
R&D budget74.1m108m124m122m---
R&D % of revenue481 %576 %375 %----
  • Edit
DateInvestorsAmountRound

N/A

Seed

$20.0m

Series A

$36.0m

Series B

$47.0m

Series C
N/A

N/A

IPO

$50.0m

Post IPO Debt
*

$205m

Post IPO Equity
*
N/A

$85.0m

Post IPO Equity
Total Funding€93.6m

Recent News about Scholar Rock

Edit
More about Scholar Rockinfo icon
Edit

Scholar Rock is a biopharmaceutical company focused on developing innovative treatments for diseases by targeting protein growth factors. Operating in the healthcare and biotechnology market, Scholar Rock serves patients and healthcare providers by offering novel therapeutic solutions. The company leverages its unique drug discovery platform to unlock new possibilities in disease treatment, particularly in areas that have been historically overlooked. Scholar Rock's business model revolves around research and development, partnerships, and collaborations with other biopharmaceutical companies and institutions. Revenue is generated through licensing agreements, milestone payments, and eventual product sales. The company is committed to patient-centric approaches and values scientific curiosity and collaboration.

Keywords: biopharmaceutical, protein growth factors, innovative treatments, drug discovery, healthcare, biotechnology, patient-centric, research and development, partnerships, collaborations.

Tech stack

Group
Tech stackLearn more about the technologies and tools that this company uses.